Close Menu

x-ray crystallography

Understanding how the enzyme positions the target DNA for cleavage could lead to new engineered Cas9 variants that increase efficiency and specificity.

Researchers get a clear image of the DROSHA protein and gain a better understanding of the Microprocessor complex involved in miRNA biogenesis. 

NEW YORK (GenomeWeb) – Three UK science funding agencies have jointly contributed £5.6 million ($9.4 million) toward the European X-ray Free Electron Lasers (XFEL) project, a facility currently under construction in Hamburg, Germany that will provide scientists with access to advanced crystallogr

NEW YORK (GenomeWeb News) – The National Science Foundation has awarded $25 million to fund a new center at the University of Buffalo that will use X-ray bioimaging technologies to analyze molecular targets for their use as therapeutic drugs, NSF said yesterday.

NEW YORK (GenomeWeb News) – For a protein that has been around for about 4 billion years, thioredoxin has gone through remarkably few changes, researchers from the University of Granada in Spain reported today in the journal Stucture.

NEW YORK (GenomeWeb News) – Scripps Research Institute has received a three-year, $2.7 million grant from the National Institute of General Medical Sciences to study the structural rules governing a class of proteins that help regulate cellular functions, such as reproduction, development, and me

Proteros will provide X-ray structural analysis of protein compound complexes for specific targets to support Rigel's drug discovery program.

Under a deal announced today, Proteros will provide structures from its Gallery Structure catalogue of ready-to-use proteins for X-ray structure analysis of protein-ligand complexes, as well as gene-to-structure projects for novel biological targets.

The firm will provide the foundation with structure-based drug discovery services.

The firms achieved a second milestone in their drug discovery pact, which utilizes Emerald's X-ray crystallography platform.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.